Information de reference pour ce titreAccession Number: | 00002413-199802000-00008.
|
Author: | McALISTER, F. A.; CLARK, H. D.; WELLS, P. S.; LAUPACIS, A.
|
Institution: | (McALISTER, CLARK, LAUPACIS) Division of General Internal Medicine, (WELLS) Division of Haematology and (McALISTER, WELLS, LAUPACIS) Clinical Epidemiology Unit, Loeb Medical Research Center, Ottawa Civic Hospital, Ottawa, Ontario, Canada.
|
Title: | Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies.[Article]
|
Source: | British Journal of Surgery. 85(2):171-178, February 1998.
|
Abstract: | Background: There is controversy over whether perioperative allogeneic red blood cell transfusions are associated with an increased risk of cancer recurrence, postoperative infection or death in patients with cancer undergoing surgery.
Methods: A systematic meta-analysis was performed to answer this question. Studies were identified from electronic databases (Medline 1966-1997, Cancerlit 1983-1997, Current Contents, Cinahl 1982-1996, Healthstar 1990-1997, Bioabstracts 1990-1996 and Embase), by hand search of the bibliographies of identified studies and relevant journals, and by contact with experts in the field. All randomized controlled trials or prospective cohort studies with active comparator controls (autologous or leucocyte-depleted allogeneic blood) were eligible for inclusion if they reported on mortality, infection or recurrence rate in patients with cancer undergoing potentially curative surgical resection. The validity of the identified studies was assessed by means of a standardized scale, and data abstraction was carried out by two investigators independently. A random effects model was used for data synthesis.
Results: Of the 2172 references identified, only 17 studies fulfilled the inclusion criteria. After exclusion of duplicate publications, six randomized controlled trials and two prospective cohort studies with appropriate concurrent controls were included in the analysis. The summary risk ratios were 0.95 (95 per cent confidence interval (c.i.) 0.79-1.15) for all-cause mortality and 1.06 (95 per cent c.i. 0.88-1.28) for cancer recurrence, the two endpoints that were appropriate to combine statistically. There was significant heterogeneity (explainable by differences in study design and patient characteristics) in the postoperative infection data and the summary risk ratio was 1.00 (95 per cent c.i. 0.76-1.32) for the four studies that were appropriate to subject to meta-analysis. Given the sample sizes of these eight studies, this meta-analysis had insufficient power to detect a relative difference of less than 20 per cent in the frequency of death, cancer recurrence or infection between the allogeneic and control transfusion arms.
Conclusion: Although more studies are required before a definitive statement can be made, at this time there is no evidence that allogeneic blood transfusion increases the risk of clinically important adverse sequelae in patients with cancer undergoing surgery.
(C) 1998 John Wiley & Sons, Ltd
|
References: | 1. Freidman BA, Burns TL, Schork MA. A study of blood utilisation by diagnosis, month of transfusion, and geographic region of the United States. Transfusion 1979; 19: 511-25.
2. Chiavetta JA, Herst R, Freedman J, Axcell TJ, Wall AJ, van Rooy SC. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996; 36: 699-706.
3. Francis DMA. Relationship between blood transfusion and tumour behaviour. Br J Surg 1991; 78: 1420-8.
4. Hallissey MT, Crowson MC, Kiff RS, Kingston RD, Fielding JWL. Blood transfusion: an overused resource in colorectal cancer surgery. Ann R Coll Surg Engl 1992; 74: 59-62.
5. Friedman BA, Burns TL, Schork MA, Kalton G. A description and analysis of current blood transfusion practices in the United States with applications for the hospital transfusion committee. In: Homburger HA, Batsakis JG, eds. Clinical Laboratory Annual. Vol. 1. New York: Appleton-Century-Crofts, 1982: 147-69.
6. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer cell activity in recipients of repeated blood transfusions. Blood 1984; 64: 308-10.
7. Gafter U, Kalechman Y, Sredni B. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int 1992; 41: 143-8.
8. Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-9.
9. Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989; 32: 749-53.
10. Gantt CL. Red blood cells for cancer patients. Lancet 1981; ii: 363 (Letter).
11. Vamvakas EC, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993; 33: 754-65.
12. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995; 35: 760-8.
13. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993; 80: 427-32.
14. Duffy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion - a meta analysis of published randomized and nonrandomized studies. Transfus Med 1996; 6: 325-8.
15. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 36: 175-86.
16. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82: 582-7.
17. Nathanson SD, Tilley BC, Schultz L, Smith RF. Perioperative allogeneic blood transfusions. Survival in patients with resected carcinomas of the colon and rectum. Arch Surg 1985; 120: 734-8.
18. Mikulin T, Powell CS, Urwin GH, Hamdy F, Fox M, Williams HL. Relation between blood transfusion and survival in renal adenocarcinoma. Br J Surg 1986; 73: 1036-7 (Abstract).
19. Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. BMJ 1985; 290: 1037-9.
20. Miettinen AS. The need for randomization in the study of intended effects. Stat Med 1983; 2: 267-71.
21. Blajchman MA, Bordin JO. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol 1994; 1: 457-61.
22. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84: 1703-21.
23. Persijn GG, Cohen B, Lansbergen Q, van Rood JJ. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation 1979; 28: 396-401.
24. Singh SK, Marquet RL, de Bruin RWF, Westbroek DL, Jeekel J. Promotion of tumour growth by blood transfusions. Transplant Proc 1987; 19: 1473-4.
25. Jensen LS, Andersen AJ, Christiansen PM et al. Post-operative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-16.
26. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996; 17: 1-12.
27. Levine M, Walter S, Lee H et al. for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. IV. How to use an article about harm. JAMA 1994; 271: 1615-19.
28. Hoynck van Papendrecht MAW, Hop W, Langenhorst BLAM, Kothe FC, Marquet RL, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: results from a randomized clinical study. Vox Sang 1992; 62: 102-7.
29. Newman JH, Bowers M, Murphy J. Reduction of postoperative infection by use of autologous reinfusion. Transfusion 1996; 36: 657 (Abstract).
30. van de Watering LM, Houbiers JG, Hermans J et al. Leukocyte depletion reduces postoperative mortality in patients undergoing cardiac surgery. Proceedings of the 24th Congress of the International Society of Blood Transfusion, Mukuhar, Japan, 1996: 37 (Abstract).
31. Maeta M, Shimizu N, Oka A et al. Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J Surg Oncol 1994; 55: 149-53.
32. Braga M, Vignali A, Radaelli G, Gianotti L, Di Carlo V. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992; 158: 531-6.
33. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986; 152: 479-82.
34. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988; 75: 789-92.
35. Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA. Breast cancer survival and perioperative blood transfusion. Surgery 1989; 106: 836-41.
36. Little AG, Wu HS, Ferguson MK et al. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990; 160: 630-3.
37. Quintiliani L, Buzzonetti A, DiGirolamo M et al. Effects of blood transfusion on the immune responsiveness and survival of cancer patients: a prospective study. Transfusion 1991; 31: 713-18.
38. Eickhoff JH, Andersen J, Laybourn C on behalf of the Danish Breast Cancer Cooperative Group. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. Br J Surg 1991; 78: 1358-51.
39. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992; 216: 633-8.
40. Sene A, Jeacock J, Robinson C, Walsh S, Kingston RD. Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer. Ann R Coll Surg Engl 1993; 75: 261-7.
41. Sibbering DM, Locker AP, Hardcastle JD, Armitage NC. Blood transfusion and survival in colorectal cancer. Dis Colon Rectum 1994; 37: 358-63.
42. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994; 167: 256-60.
43. Harder F, Laffer U, Berres M, Jaggi P, Metzger U. Transfusion sanguine, chimiotherapie intraportale perioperatoire de courte duree et recidive du cancer colorectal. Chirurgie 1989; 115: 759-66.
44. Heslin MJ, Gaynor JJ, Newman E et al. Effect of perioperative blood transfusion on recurrence and survival in 232 primary high-grade extremity sarcoma patients. Ann Surg Oncol 1994; 1: 189-97.
45. Laffer U, Jaggi P, Harder F et al. Bluttransfusionen und die prognose nach kurativer resektion kolorektaler karzinome: besteht eine assoziation? Helv Chir Acta 1989; 56: 461-4.
46. Vente JP, Wiggers T, Weidema WF, Jeekel J, Obertop H. Peri-operative blood transfusions in colorectal cancer. Eur J Surg Oncol 1989; 15: 371-4.
47. Kikuchi K, Narige S, Yamahata K et al. Postoperative follow-up results of patients with non-small cell lung cancer (stage 1) who received autologous blood transfusion. Nippon Kyobu Geka Gakkai Zasshi 1996; 44: 315-16.
48. Garau I, Benito E, Bosch FX et al. Blood transfusion has no effect on colorectal cancer survival. A population-based study. Eur J Cancer 1994; 30A: 759-64.
49. Robbins KT, Favrot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck 1990; 12: 143-8.
50. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-72.
51. Vignali A, Braga M, Gianotti L et al. A single unit of transfused allogeneic blood increases postoperative infections. Vox Sang 1996; 71: 170-5.
52. Vignali A, Braga M, Dionigi P et al. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg 1995; 161: 487-92.
53. von Doersten P, Cruz RM, Selby JV, Hilsinger RL Jr. Transfusion, recurrence, and infection in head and neck cancer surgery. Otolaryngol Head Neck Surg 1992; 106: 60-7.
54. Mezrow CK, Bergstein I, Tartter PI. Postoperative infections following autologous and homologous blood transfusions. Transfusion 1992; 32: 27-30.
55. Blumberg N, Chuang-Stein C, Heal JM. The relationship of blood transfusion, tumor staging, and cancer recurrence. Transfusion 1990; 30: 291-4.
56. Mecklin JP, Jarvinen HJ, Ovaska JT. Blood transfusion and prognosis in colorectal carcinoma. Scand J Gastroenterol 1989; 24: 33-9.
57. Jensen LS, Andersen AJ, Christiansen PM et al. Blood transfusion increases the risk of surgical infection. Ugeskr Laeger 1993; 155: 3263-6.
58. Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996; 83: 973-7.
59. Heiss MM, Jauch KW, Delanoff C, Mempel W, Schildberg FW. Blood transfusion modulated tumor recurrence: a randomized study of autologous vs. homologous blood transfusion in colorectal cancer. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1992; 11: A503 (Abstract).
60. Heiss MM, Mempel W, Delanoff C, Mempel M, Jauch KW, Schildberg FW. Clinical effects of blood transfusion-associated immune modulation on outcome of tumor surgery. Infusionsther Transfusionsmed 1993; 20(Suppl 2): 25-9.
61. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 1994; 220: 791-7.
62. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. Prognostic impact of blood transfusions on disease-free survival in colorectal carcinoma. Scand J Gastroenterol 1993; 200(Suppl): 21-3.
63. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. The effect of blood transfusions on survival after surgery for colorectal cancer. Eur J Cancer 1995; 31A: 1226-8.
64. Houbiers JG, van de Velde CJ, van de Watering LM et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997; 37: 126-34.
65. Heiss MM, Mempel W, Jauch KW et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-33.
66. Heiss MM, Mempel W, Delanoff C et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-67.
67. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomized comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-5.
68. Houbiers JGA, Brand A, van de Watering LMG et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-8.
69. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-6.
70. Kajikawa M, Nonami T, Kurokawa T et al. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin. Surgery 1994; 115: 727-34.
71. Ness PM, Walsh PC, Zahurak M, Baldwin ML, Piantadosi S. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion 1992; 32: 31-6.
72. Giurati G, Zanetta G, Caspani L et al. Autologous blood transfusion in patients undergoing radical hysterectomy. Br J Obstet Gynaecol 1995; 102: 64-5.
73. Goodman SN. Have you ever meta-analysis you didn't like? Ann Intern Med 1991; 114: 244-6 (Editorial).
74. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion 1997; 37: 121-5.
75. Borzak S, Ridker PM. Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 1995; 123: 873-7.
76. Spoor P, Airey M, Bennett C, Greensill J, Williams R. Use of the capture-recapture technique to evaluate the completeness of systematic literature searches. BMJ 1996; 313: 342-3.
77. Dickersin K, Min Y-I, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 1992; 267: 374-8.
78. Enblad P, Adami HO, Bergstrom R, Glimelius B, Krusemo U, Pahlman L. Improved survival of patients with cancers of the colon and rectum? J Natl Cancer Inst 1988; 80: 586-91.
79. Roncucci L, Fante R, Losi L et al. Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer 1996; 32A: 295-302.
80. Wallace EL, Churchill WH, Surgenor DM et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995; 35: 802-12.
81. Etchason J, Petz L, Keeler E et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332: 719-24.
82. Forgie M, Wells P, Laupacis A, Fergusson D for the ISPOT investigators. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red cell transfusion: results of a meta-analysis. Arch Intern Med 1998 (in press).
83. Cohen JA, Brecher ME. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion 1995; 35: 640-4.
|
Language: | English.
|
Document Type: | Original Articles.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0007-1323
|
NLM Journal Code: | b34, 0372553
|
Annotation(s) | |
|
|